您当前的位置：
首页 >
文章列表页 >
Efficacy and safety of cholesterol absorption inhibitors combined with statins in the treatment of dyslipidemia：a network meta-analysis
更新时间：2026-07-28

    • Efficacy and safety of cholesterol absorption inhibitors combined with statins in the treatment of dyslipidemia：a network meta-analysis

    • ZHONGGUO YAOFANG   Vol. 37, Issue 14, Pages: 1912-1917(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.14.19    

      CLC： R972+.6

    • Received：14 January 2026，

      Revised：2026-06-22，

      Accepted：29 June 2026，

      Online First：24 July 2026，

      Published：30 July 2026

    移动端阅览

  • HUANG Gerile,GUO Hao,LI Yujie,et al.Efficacy and safety of cholesterol absorption inhibitors combined with statins in the treatment of dyslipidemia：a network meta-analysis[J].ZHONGGUO YAOFANG,2026,37(14):1912-1917. DOI： 10.6039/j.issn.1001-0408.2026.14.19.

  •  
  •  

0

Views

1

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Network meta-analysis of the efficacy and safety of dual amoxicillin-based regimens for Helicobacter pylori eradication
我院他汀类药物用于降脂治疗中的不良反应185例分析
瑞舒伐他汀联合依折麦布治疗冠心病急性心肌梗死的临床观察Δ
依折麦布联合辛伐他汀治疗膜性肾病合并高脂血症的临床观察
瑞舒伐他汀对血脂异常的老年患者血脂及甲状腺结节的影响

Related Author

DUAN Fei
GUO Sihan
WEI Peihan
SHE Jianpeng
HUANG Yixu
YANG Lingshu
HE Yufang
LUO Liyuan

Related Institution

Dept. of Spleen， Stomach and Hepatobiliary Disease， the First Affiliated Hospital of Henan University of CM
The First Clinical Medical College， Henan University of Chinese Medicine
0